Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2024

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Deemed “Awardable” by DoD’s Tradewinds Solutions Marketplace

Posted on November 6, 2024 by MissionIR

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”) announced it has achieved “Awardable” status in the US Department of Defense’s (DoD) Tradewinds Solutions Marketplace, which showcases cutting-edge technologies for potential DoD adoption. This designation endorses D-Wave’s annealing quantum computing technology as a vetted … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Annovis Bio Inc. (NYSE: ANVS) Highlights Buntanetap Results at 17th Clinical Trials on Alzheimer’s Disease (‘CTAD’) 2024 Conference

Posted on November 5, 2024 by MissionIR

Annovis (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), presented two scientific posters at the 17th Clinical Trials on Alzheimer’s Disease (“CTAD”) conference (https://ibn.fm/ysPFn), held … Continue reading →

Posted in Annovis Bio Inc. ANVS | Leave a comment

The US Announces New Strategy to Help It Dominate the AI Race

Posted on November 1, 2024 by MissionIR

President Biden has rolled out a new plan aimed at enabling the U.S. to harness AI for national security purposes amid a global race that is seeing different countries scrambling to tap this new technology for their own interests. He … Continue reading →

Posted in McEwen Mining Inc. MUX | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Granted Nasdaq Extension for Compliance 

Posted on November 1, 2024 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP) announced that it received an exception from the Nasdaq Hearings Panel, granting the company until March 11, 2025, to meet the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This extension allows CNS additional time … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Secures Nasdaq Compliance, Continues Listing Under Monitoring Period

Posted on November 1, 2024 by MissionIR

SOBRsafe (NASDAQ: SOBR) announced its compliance with Nasdaq’s listing standards, meeting minimum bid price, public float, and stockholders’ equity requirements per the August 2024 Nasdaq Hearings Panel decision. As a result, SOBRsafe’s common stock will remain listed on the Nasdaq … Continue reading →

Posted in SOBRsafe Inc. SOBR | Leave a comment